Biosimilar program
At Teva, we understand a healthy biosimilars pipeline is a valuable part of our future. Which is why we’re determined to lead the way in innovating quality, affordable and accessible biosimilars.
See the many biologic and biosimilars development programs at multiple stages in our pipeline.
Learn more
2021 Teva Pharmaceuticals, Inc. NPS-40382 November 2021. This site is intended for US residents only.